UPDATED: Nov. 2022
Here are brief descriptions of some of the
cannabis medical patents. The patent numbers were links to the full patent. However,
due to the new patents office website, the links were broken. The
government (probably during the Trump's presidency), changed the
way we search for patents in the Patents website, because they do
not want you to know that they own some of the cannabis medical
patents, because it shows their hypocrisy. The DEA has
Cannabis as a schedule 1 narcotic (narcotics with NO medical use),
this is contradictory to the medical patents they own. The broken
links have been replaced by the patent number in the color red.
However, you can use a web search engine to find the patents in
websites other than the Patents office website.
The links to PDF files, of some of the patents, still work because
I downloaded the files of some of the patent's abstracts, before
the Trump's administration changed the Patents Office website,
where only certain people are now allowed to look at certain
patents.
US 6630507 (2003).
CANNABINOIDS AS ANTIOXIDANT AND NEUROPROTECTANTS. (Owned by
the Department of Health and Human Services, Wash D.C.
USA) They claim it can be used to treat Parkinson's,
Alzheimer’s, HIV dementia, MS, & other
neurodegenerative diseases.
US
5939429 (1999) Cardiovascular uses of cannabinoid
compounds. Hemorrhagic shock and other conditions associated
with excessive vasoconstriction, such as hypertension,
peripheral vascular disease, cirrhosis of the liver, or
certain forms of angina pectoris can be treated by using
agonists of CB1 receptors as well as other cannabinoid
receptors. In addition, it has been determined that in septic
shock and cirrhosis of the liver when hypotension is due to
activation of macrophages by bacterial endotoxin, the use of a
drug that selectively blocks CB1 receptors or other
cannabinoid receptors may be of therapeutic value by
preventing or attenuating the endotoxin-induced hypotension.
US 6410588 (2002).
USE OF CANNABINOIDS AS ANTI-INFLAMMATORY AGENTS. (Owned by the
Hebrew University of Jerusalem). They claim it can be used to
treat inflammatory diseases such as IBD, IBS, Celiac,
Rheumatoid Arthritis, Chron's disease, Sarcodosis, Asthma,
Multiple Sclerosis, Psoriasis, Ulcerative Colitis,
Osteoarthritis, Alzheimer's disease, etc..)
US 6331560 TUMOR NECROSIS FACTOR
ALPHA (TNF-a) INHIBITING PHARMACEUTICAL.
US
6610737 (2003). NON-PSYCHOTROPIC CANNABINOIDS Used to
prevent neurotoxidity, neuroinflammation, and immune or
inflammatory disorders. The compositions are
particularly effective in alleviating and even preventing
neurotoxicity due to acute injuries to the central nervous
system, including mechanical trauma, compromised or reduced
blood supply as may occur in cardiac arrest or stroke, or
poisonings. Also effective in the treatment of certain
inflammatory disorders and chronic degenerative diseases
characterized by neuronal loss and chronic pain including
neuropathic pain.
US 7358245 B2 (2008) Treatment of
gastroesophageal reflux disease -Use of cannabinoid
receptor agonists for the treatment of gastroesophageal reflux
disease, as well as for the treatment of regurgitation such as
regurgitation in infants, lung disease, chronic laryngitis and
asthma.
US
7807711 (2010). MEDICINAL ACIDIC CANNABINOIDS. This
one is for treating chronic fatigue and immune system
disorders. (Owned by the Netherlands).
US 7597910 (2009). This one is
about using zinc and selenium enriched Cannabis plants &
mushrooms to treat PROSTATE CANCER and prostate
disorders.
US
6974568 (2005) Treatment for cough. The
invention discloses the existence of cannabinoid receptors
in the airways, which are functionally linked to inhibition
of cough.
US 6949582 (2005) Method of
relieving analgesia and reducing inflammation using a
cannabinoid delivery topical liniment.
RETURN TO
CANNABIS, THE GOOD, THE BAD, & THE UGLY
RETURN TO
INTRODUCTION TO CANNABIS